Viking inks CordenPharma deal to boost obesity drug supply
The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched weight loss treatment.
The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched weight loss treatment.
